Chloroprocaine Hydrochloride is Used for regional anesthesia through intrathecal administration. It was first introduced by Fresenius Kabi Usa Llc in its drug Nesacaine on Approved Prior to Jan 1, 1982. Other drugs containing Chloroprocaine Hydrochloride are Iheezo, Nesacaine-Mpf, Clorotekal. 5 different companies have introduced drugs containing Chloroprocaine Hydrochloride.

Chloroprocaine Hydrochloride Patents

Given below is the list of patents protecting Chloroprocaine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Iheezo	US11969403	Topical formulations of chloroprocaine and methods of using same	May 14, 2039	Harrow Eye
Iheezo	US10792271	Topical formulations of chloroprocaine and methods of using same	Sep 15, 2038	Harrow Eye
Clorotekal	US9504666	Chloroprocaine-based pharmaceutical composition for repeated intrathecal administration	Dec 11, 2033	B Braun Medical
Clorotekal	US8969412	Use for a composition comprising chloroprocaine HCL, a new composition comprising chloroprocaine HCL and a method for its manufacture	Sep 05, 2026	B Braun Medical

Add above patents to watchlist

Chloroprocaine Hydrochloride's Family Patents

Full family tree

Chloroprocaine Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Chloroprocaine Hydrochloride. The first generic version for Chloroprocaine Hydrochloride was by Hospira Inc and was approved on Apr 16, 1982. And the latest generic version is by Hikma Pharmaceuticals Usa Inc and was approved on Sep 9, 1998.

Given below is the list of companies who have filed for Chloroprocaine Hydrochloride generic, along with the locations of their manufacturing plants worldwide.